311 related articles for article (PubMed ID: 9642119)
1. Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression.
Ahmad N; Gali H; Javed S; Agarwal R
Biochem Biophys Res Commun; 1998 Jun; 247(2):294-301. PubMed ID: 9642119
[TBL] [Abstract][Full Text] [Related]
2. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.
Zi X; Grasso AW; Kung HJ; Agarwal R
Cancer Res; 1998 May; 58(9):1920-9. PubMed ID: 9581834
[TBL] [Abstract][Full Text] [Related]
3. Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate-caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1alpha expression in SENCAR mouse epidermis: implications in the prevention of stage I tumor promotion.
Zhao J; Sharma Y; Agarwal R
Mol Carcinog; 1999 Dec; 26(4):321-33. PubMed ID: 10569809
[TBL] [Abstract][Full Text] [Related]
4. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model.
Lahiri-Chatterjee M; Katiyar SK; Mohan RR; Agarwal R
Cancer Res; 1999 Feb; 59(3):622-32. PubMed ID: 9973210
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
[TBL] [Abstract][Full Text] [Related]
6. Modulation of mitogen-activated protein kinase activation and cell cycle regulators by the potent skin cancer preventive agent silymarin.
Zi X; Agarwal R
Biochem Biophys Res Commun; 1999 Sep; 263(2):528-36. PubMed ID: 10491326
[TBL] [Abstract][Full Text] [Related]
7. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
Wang Z; Wang M; Carr BI
J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308
[TBL] [Abstract][Full Text] [Related]
8. Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice.
Xian W; Kiguchi K; Imamoto A; Rupp T; Zilberstein A; DiGiovanni J
Cell Growth Differ; 1995 Nov; 6(11):1447-55. PubMed ID: 8562483
[TBL] [Abstract][Full Text] [Related]
9. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling.
Mallikarjuna G; Dhanalakshmi S; Singh RP; Agarwal C; Agarwal R
Cancer Res; 2004 Sep; 64(17):6349-56. PubMed ID: 15342425
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase.
Moyer JD; Barbacci EG; Iwata KK; Arnold L; Boman B; Cunningham A; DiOrio C; Doty J; Morin MJ; Moyer MP; Neveu M; Pollack VA; Pustilnik LR; Reynolds MM; Sloan D; Theleman A; Miller P
Cancer Res; 1997 Nov; 57(21):4838-48. PubMed ID: 9354447
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation.
Gschwind A; Prenzel N; Ullrich A
Cancer Res; 2002 Nov; 62(21):6329-36. PubMed ID: 12414665
[TBL] [Abstract][Full Text] [Related]
12. Differential responses of EGFR-/AGT-expressing cells to the "combi-triazene" SMA41.
Matheson SL; McNamee JP; Jean-Claude BJ
Cancer Chemother Pharmacol; 2003 Jan; 51(1):11-20. PubMed ID: 12497201
[TBL] [Abstract][Full Text] [Related]
13. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive efficacy of silymarin in skin and prostate cancer.
Deep G; Agarwal R
Integr Cancer Ther; 2007 Jun; 6(2):130-45. PubMed ID: 17548792
[TBL] [Abstract][Full Text] [Related]
15. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R
Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451
[TBL] [Abstract][Full Text] [Related]
16. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma.
Liu Y; Poon RT; Shao W; Sun X; Chen H; Kok TW; Fan ST
Cancer Lett; 2007 Apr; 248(1):32-40. PubMed ID: 16837130
[TBL] [Abstract][Full Text] [Related]
17. K vitamins, PTP antagonism, and cell growth arrest.
Carr BI; Wang Z; Kar S
J Cell Physiol; 2002 Dec; 193(3):263-74. PubMed ID: 12384979
[TBL] [Abstract][Full Text] [Related]
18. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
Xian W; Rosenberg MP; DiGiovanni J
Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives.
Kelloff GJ; Fay JR; Steele VE; Lubet RA; Boone CW; Crowell JA; Sigman CC
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):657-66. PubMed ID: 8824370
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma.
Thomas SM; Bhola NE; Zhang Q; Contrucci SC; Wentzel AL; Freilino ML; Gooding WE; Siegfried JM; Chan DC; Grandis JR
Cancer Res; 2006 Dec; 66(24):11831-9. PubMed ID: 17178880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
